EUVIMEDOpdag EUVIMED
Open access

Microglia‐Mediated Synaptic Dysfunction Contributes to Chemotherapy‐Related Cognitive Impairment

Jingxiong Wang, Hua Zhang, Marc Augenreich, Luis Martinez-Lemus A, Zhenguo Liu, Xunlei Kang, Bo Lu, Hui-Ming Chang, Edward T H Yeh, Juan Cata, Srikant Rangaraju, Heike Wulff and 1 more

Journal of Neurochemistry · 2025-03 · 169 (3)

DOI: 10.1111/jnc.70024 ↗

At a glance

Journal article in Journal of Neurochemistry, published online on 2025-02-28. Written by Jingxiong Wang and 12 co-authors. Institution: Department of Medicine, University of Missouri-Columbia School of Medicine, Columbia, Missouri, USA. Major MEDLINE topics: Microglia, Chemotherapy-Related Cognitive Impairment, Synapses, Cognitive Dysfunction. Cited 8 times so far (Crossref); 84 references. The full text is freely available in PubMed Central. Funded by: NHLBI NIH HHS, Department of Medicine, Center for Precision MedicineUniversity of Missouri, National Heart, Lung, and Blood Institute.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Chemotherapy‐related cognitive impairment (CRCI) significantly impacts cancer survivors. Due to unclear mechanisms, effective treatments for cognitive deficits are lacking. Here, we examined if microglia‐mediated deficits in synaptic plasticity drive CRCI. Adult male mice were treated with the chemotherapeutic drugs 5‐fluorouracil and leucovorin (5‐Fu/LV, intraperitoneal injection, I.P.) on Days 1, 8, and 15 at a dosage of 50 mg/kg for 5‐Fu and 90 mg/kg for LV for 3 weeks. Cognitive function was assessed using a novel object recognition (NOR) test 4 weeks after completion of 5‐Fu/LV treatment. Compared with vehicle treatment, 5‐Fu/LV treatment reduced the preference for exploring novel objects in the NOR test. Treatment with 5‐Fu/LV increased the numbers of Iba1‐positive microglial and CD68‐positive/Iba1‐positive microglia with shortened process lengths and diminished endpoints but decreased the number of phagocytotic (≤ 1 FITC‐labeled beads) Iba1‐positive microglia. Furthermore, 5‐Fu/LV treatment reduced the long‐term potentiation (LTP) recorded in the hippocampal CA1 region in response to a theta burst stimulation of the CA3‐CA1 pathway and decreased the evoked N‐methyl‐D‐aspartic acid receptor (NMDAR)‐excitatory postsynaptic currents (NMDAR‐EPSCs) in CA1 neurons. Cotreatment with the microglial inhibitor minocycline (33 mg/kg, daily for 3 weeks) restored cognitive deficits and microglial ramification, decreased the number of CD68‐positive microglia, and reversed the reductions in LTP and the amplitude of NMDAR‐EPSCs in 5‐Fu/LV‐treated mice. Our data suggest that microglial dysfunction and related synaptic dysfunction contribute to 5‐Fu/LV‐induced cognitive impairment. image

Subjects

MeSH terms (MEDLINE)

MicrogliaChemotherapy-Related Cognitive ImpairmentSynapsesCognitive DysfunctionAnimalsMaleMiceFluorouracilMice, Inbred C57BLLong-Term PotentiationNeuronal Plasticity

Author keywords

chemotherapycognitive deficitslong‐term potentiationmicrogliasynaptic transmission

Substances

Fluorouracil

Authors and institutions

  • Department of Medicine, University of Missouri-Columbia School of Medicine, Columbia, Missouri, USA.
  • Department of Medical Pharmacology and Physiology, University of Missouri-Columbia School of Medicine, Columbia, Missouri, USA.
  • Department of Radiation Oncology, NextGen Precision Health, University of Missouri-Columbia School of Medicine, Columbia, Missouri, USA.
  • Departments of Pharmacology and Internal Medicine, The University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Department of Internal Medicine, The University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Department of Anesthesiology and Perioperative Medicine, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.

ORCID profiles: De-Pei Li

Funding

  • NHLBI NIH HHS
  • Department of Medicine, Center for Precision MedicineUniversity of Missouri
  • National Heart, Lung, and Blood Institute

Cite

APA

Wang, J., Zhang, H., Augenreich, M., Martinez-Lemus A, L., Liu, Z., Kang, X., Lu, B., Chang, H. M., Yeh, E. T. H., Cata, J., Rangaraju, S., Wulff, H., & Li, D. P. (2025). Microglia‐Mediated Synaptic Dysfunction Contributes to Chemotherapy‐Related Cognitive Impairment. Journal of Neurochemistry, 169(3). https://doi.org/10.1111/jnc.70024

Vancouver

Wang J, Zhang H, Augenreich M, Martinez-Lemus A L, Liu Z, Kang X, et al. Microglia‐Mediated Synaptic Dysfunction Contributes to Chemotherapy‐Related Cognitive Impairment. Journal of Neurochemistry. 2025;169(3). doi:10.1111/jnc.70024

BibTeX
@article{Wang2025,
  author = {Wang, Jingxiong and Zhang, Hua and Augenreich, Marc and Martinez-Lemus A, Luis and Liu, Zhenguo and Kang, Xunlei and Lu, Bo and Chang, Hui-Ming and Yeh, Edward T H and Cata, Juan and Rangaraju, Srikant and Wulff, Heike and Li, De-Pei},
  title = {Microglia‐Mediated Synaptic Dysfunction Contributes to Chemotherapy‐Related Cognitive Impairment},
  journal = {Journal of Neurochemistry},
  year = {2025},
  volume = {169},
  number = {3},
  doi = {10.1111/jnc.70024}
}
Start for free →